ANI Pharmaceuticals 

$81.68
26
+$0.03+0.04% Friday 20:00

Statistics

Day High
83.66
Day Low
80.75
52W High
98.81
52W Low
61.96
Volume
179,800
Avg. Volume
-
Mkt Cap
1.83B
P/E Ratio
20.76
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
1.09
1.41
1.73
2.05
Expected EPS
2.021375
Actual EPS
N/A

Financials

8.74%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.77BRevenue
154.36MNet Income

Analyst Ratings

124.00Average Price Target
The highest estimate is 124.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ANIP. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

ANI Pharmaceuticals, Inc. operates as a biopharmaceutical firm, concentrating on the development, production, and commercialization of both proprietary (branded) and unbranded (generic) prescription medications across the United States and Canada. The company's primary focus areas include manufacturing controlled substances, treatments for oncology, hormones and steroids, injectable drugs, and various other pharmaceutical preparations. Its robust manufacturing capabilities encompass a range of dosage forms, such as oral solid products, semi-solids, liquid formulations, and topical agents, as well as highly potent compounds. Furthermore, ANI Pharmaceuticals provides contract development and manufacturing services to other pharmaceutical enterprises. The company distributes its products through a diverse network, which includes retail pharmacy chains, wholesalers, distributors, mail-order pharmacies, and group purchasing organizations. Incorporated in 2001, its corporate headquarters are situated in Baudette, Minnesota.
Show more...
CEO
Mr. Nikhil Lalwani
Employees
897
Country
United States
ISIN
US00182C1036

Listings

0 Comments

Share your thoughts

FAQ

What is ANI Pharmaceuticals stock price today?
The current price of ANIP is $81.68 USD — it has increased by +0.04% in the past 24 hours. Watch ANI Pharmaceuticals stock price performance more closely on the chart.
What is ANI Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ANI Pharmaceuticals stocks are traded under the ticker ANIP.
Is ANI Pharmaceuticals stock price growing?
ANIP stock has risen by +0.7% compared to the previous week, the month change is a +0.99% rise, over the last year ANI Pharmaceuticals has showed a +30.56% increase.
What is ANI Pharmaceuticals market cap?
Today ANI Pharmaceuticals has the market capitalization of 1.83B
When is the next ANI Pharmaceuticals earnings date?
ANI Pharmaceuticals is going to release the next earnings report on August 12, 2026.
What were ANI Pharmaceuticals earnings last quarter?
ANIP earnings for the last quarter are 2.05 USD per share, whereas the estimation was 1.3 USD resulting in a +57.84% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ANI Pharmaceuticals revenue for the last year?
ANI Pharmaceuticals revenue for the last year amounts to 1.77B USD.
What is ANI Pharmaceuticals net income for the last year?
ANIP net income for the last year is 154.36M USD.
How many employees does ANI Pharmaceuticals have?
As of June 13, 2026, the company has 897 employees.
In which sector is ANI Pharmaceuticals located?
ANI Pharmaceuticals operates in the Health & Wellness sector.
When did ANI Pharmaceuticals complete a stock split?
The last stock split for ANI Pharmaceuticals was on July 18, 2013 with a ratio of 1:6.
Where is ANI Pharmaceuticals headquartered?
ANI Pharmaceuticals is headquartered in Baudette, United States.